SLC6A6
Basic information
Region (hg38): 3:14402576-14489349
Links
Phenotypes
GenCC
Source:
- hypotaurinemic retinal degeneration and cardiomyopathy (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Hypotaurinemic retinal degeneration and cardiomyopathy | AR | Biochemical; Cardiovascular | Oral taurine supplementation has been described as being beneficial; Individuals have been described with cardiomyopathy, and awareness may allow early diagnosis and management of cardiac sequelae | Biochemical; Cardiovascular; Ophthalmologic | 31345061; 31903486 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (62 variants)
- not_provided (3 variants)
- Hypotaurinemic_retinal_degeneration_and_cardiomyopathy (3 variants)
- Retinal_degeneration (2 variants)
- Retinal_dystrophy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC6A6 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003043.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | |||||
| missense | 59 | 64 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 1 | 2 | 60 | 3 | 2 |
Highest pathogenic variant AF is 6.885535e-7
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SLC6A6 | protein_coding | protein_coding | ENST00000454876 | 13 | 86782 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.990 | 0.0101 | 125741 | 0 | 7 | 125748 | 0.0000278 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.39 | 191 | 376 | 0.508 | 0.0000219 | 4045 |
| Missense in Polyphen | 55 | 181.42 | 0.30317 | 2047 | ||
| Synonymous | 0.263 | 155 | 159 | 0.973 | 0.0000107 | 1230 |
| Loss of Function | 4.53 | 4 | 31.4 | 0.127 | 0.00000143 | 352 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000289 | 0.0000289 |
| Ashkenazi Jewish | 0.0000993 | 0.0000992 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000264 | 0.0000264 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.00 | 0.00 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Sodium-dependent taurine and beta-alanine transporter. Chloride ions are necessary for optimal uptake. {ECO:0000269|PubMed:8382624}.;
- Pathway
- Nuclear Receptors Meta-Pathway;NRF2 pathway;Amine compound SLC transporters;Amino acid transport across the plasma membrane;Amino acid and oligopeptide SLC transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Transport of small molecules;Bile acid biosynthesis;Na+/Cl- dependent neurotransmitter transporters
(Consensus)
Intolerance Scores
- loftool
- 0.301
- rvis_EVS
- -0.29
- rvis_percentile_EVS
- 33.2
Haploinsufficiency Scores
- pHI
- 0.328
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.569
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.266
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc6a6
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- slc6a6b
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- lethal (sensu genetics)
Gene ontology
- Biological process
- amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport
- Cellular component
- plasma membrane;integral component of plasma membrane;integral component of membrane
- Molecular function
- neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity